新股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

制药与医学研究概念

NaN

0.0000.22%

涨家数：2

跌家数：1

平家数：3

市盈率：- -

高：NaN

开：NaN

低：NaN

收：NaN

成交量：1,552.71万

成交额：1,233.06万

市值：69.53亿

流通市值：40.62亿

数据加载中...

总览新闻资讯

IX生物制药拟定向增发募资不低于600万新元已获Lqn通知函

IX生物制药拟定向增发募资不低于600万新元签署配售协议

美国政府授予IX生物制药4100万美元合约资助Wafermine药物研发

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK6506/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK6506","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","market":"SI","secType":"PLATE","nameCN":"制药与医学研究概念","latestPrice":3.049655e-8,"timestamp":1771837770814,"preClose":3.0430805e-8,"halted":0,"volume":15527100,"delay":0,"changeRate":0.002161,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":0,"latestTime":"02-23 17:16:00 SGT","open":3.043396e-8,"high":3.0955896e-8,"low":3.025575e-8,"amount":12330551.5,"amplitude":0.023008,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771893000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1771806600000,1771819200000],[1771822800000,1771838160000]],"pbRate":1.64093,"peRate":10.506501,"turnoverRate":0.013003,"increases":2,"decrements":1,"flats":4,"marketCap":6952997016,"floatMarketCap":4061926971.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","high":3.0955896e-8,"amplitude":0.023008,"preClose":3.0430805e-8,"low":3.025575e-8,"pbRate":"1.64093","latestPrice":3.049655e-8,"volume":15527100,"delay":0,"open":3.043396e-8,"prevYearClose":1.4808467e-7,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0,"secType":"PLATE","market":"SI","turnoverRate":0.013003,"peRate":10.506501,"marketCap":6952997016,"floatMarketCap":4061926971.75,"timestamp":1771837770814,"nameCN":"制药与医学研究概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK6506\",,,,undefined,":{"bkCode":"BK6506","up":2,"down":1,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK6506\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194800224","title":"IX生物制药拟定向增发募资不低于600万新元 已获Lqn通知函","url":"https://stock-news.laohu8.com/highlight/detail?id=1194800224","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194800224?lang=zh_cn&edition=fundamental","pubTime":"2026-02-19 18:47","pubTimestamp":1771498033,"startTime":"0","endTime":"0","summary":"IX生物制药有限公司宣布启动一项定向增发计划，旨在募集总额不低于600万新加坡元的资金。公司已正式收到Lqn通知函，标志着融资进程进入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["42C.SI","BK6506","BK6079"],"gpt_icon":0},{"id":"1109166435","title":"IX生物制药拟定向增发募资不低于600万新元 签署配售协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1109166435","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109166435?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 18:53","pubTimestamp":1770893592,"startTime":"0","endTime":"0","summary":"IX生物制药有限公司宣布启动定向增发计划，拟募集资金总额不低于600万新元。公司已正式签署配售协议，标志着此次融资活动进入实质性推进阶段。本次募资将用于支持公司核心业务发展及管线药物研发，进一步巩固其在生物医药领域的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6079","42C.SI","BK6506"],"gpt_icon":0},{"id":"1165474960","title":"美国政府授予IX生物制药4100万美元合约 资助Wafermine药物研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1165474960","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165474960?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 18:46","pubTimestamp":1770893172,"startTime":"0","endTime":"0","summary":"美国政府与IX生物制药签署价值4100万美元的研发合约，专项用于支持其创新药物Wafermine的临床开发。该资金将加速这款针对神经系统疾病的口服速溶薄膜制剂的技术攻关与产业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6506","BK6079","42C.SI"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}